Influence of Sodium Substitutes on 5-HT-mediated Effects at Mouse 5-HT3 Receptors

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2004 May 19

PMID 15148263

Citations 2

Authors

M Barann

K Schmidt

M Gothert

B W Urban

H Bonisch

Affiliations

Soon will be listed here.

Abstract

1 The influence of sodium ion substitutes on the 5-hydroxytryptamine (5-HT)-induced flux of the organic cation [14C]guanidinium through the ion channel of the mouse 5-HT3 receptor and on the competition of 5-HT with the selective 5-HT3 receptor antagonist [3H]GR 65630 was studied, unless stated otherwise, in mouse neuroblastoma N1E-115 cells. 2 Under physiological conditions (135 mm sodium), 5-HT induced a concentration-dependent [14C]guanidinium influx with an EC50 (1.3 microm) similar to that in electrophysiological studies. 3 The stepwise replacement of sodium by increasing concentrations of the organic cation hydroxyethyl trimethylammonium (choline) concentration dependently caused both a rightward shift of the 5-HT concentration-response curve and an increase in the maximum effect of 5-HT. Complete replacement of sodium resulted in a 34-fold lower potency of 5-HT and an almost two times higher maximal response. A low potency of 5-HT in choline buffer was also observed in other 5-HT3 receptor-expressing rodent cell lines (NG 108-15 or NCB 20). 4 Replacement of Na+ by Li+ left the potency and maximal effects of 5-HT almost unchanged. Replacement by tris (hydroxymethyl) methylamine (Tris), tetramethylammonium (TMA) or N-methyl-d-glucamine (NMDG) caused an increase in maximal response to 5-HT similar to that caused by choline. The potency of 5-HT was only slightly reduced by Tris, to a high degree decreased by TMA (comparable to the decrease by choline), but not influenced by NMDG. 5 The potency of 5-HT in inhibiting [3H]GR65630 binding to intact cells was 35-fold lower when sodium was completely replaced by choline, but remained unchanged after replacement by NMDG. 6 The results are compatible with the suggestion that choline competes with 5-HT for the 5-HT3 receptor; the increase in maximal response may be partly due to a choline-mediated delay of the 5-HT-induced desensitization. For studies of 5-HT-evoked [14C]guanidinium flux through 5-HT3 receptor channels, NMDG appears to be an 'ideal' sodium substituent since it increases the signal-to-noise ratio without interfering with 5-HT binding.

Citing Articles

Serotonin and beyond-a tribute to Manfred Göthert (1939-2019).

Bonisch H, Fink K, Malinowska B, Molderings G, Schlicker E Naunyn Schmiedebergs Arch Pharmacol. 2021; 394(9):1829-1867.

PMID: 33991216 PMC: 8376721. DOI: 10.1007/s00210-021-02083-5.

The Traditional Japanese Medicine Rikkunshito Promotes Gastric Emptying via the Antagonistic Action of the 5-HT(3) Receptor Pathway in Rats.

Tominaga K, Kido T, Ochi M, Sadakane C, Mase A, Okazaki H Evid Based Complement Alternat Med. 2009; 2011:248481.

PMID: 19861508 PMC: 3095508. DOI: 10.1093/ecam/nep173.

References

Furukawa K, Akaike N, Onodera H, Kogure K . Expression of 5-HT3 receptors in PC12 cells treated with NGF and 8-Br-cAMP. J Neurophysiol. 1992; 67(4):812-9. DOI: 10.1152/jn.1992.67.4.812. View

Voog O, Alstergren P, Leibur E, Kallikorm R, Kopp S . Immediate effects of the serotonin antagonist granisetron on temporomandibular joint pain in patients with systemic inflammatory disorders. Life Sci. 2001; 68(5):591-602. DOI: 10.1016/s0024-3205(00)00965-6. View

Werner P, Kawashima E, Reid J, Hussy N, Lundstrom K, Buell G . Organization of the mouse 5-HT3 receptor gene and functional expression of two splice variants. Brain Res Mol Brain Res. 1994; 26(1-2):233-41. DOI: 10.1016/0169-328x(94)90095-7. View

Kilpatrick G, Jones B, Tyers M . Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species. Eur J Pharmacol. 1989; 159(2):157-64. DOI: 10.1016/0014-2999(89)90700-0. View

Maricq A, Peterson A, Brake A, Myers R, Julius D . Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science. 1991; 254(5030):432-7. DOI: 10.1126/science.1718042. View

Robertson B, Bevan S . Properties of 5-hydroxytryptamine3 receptor-gated currents in adult rat dorsal root ganglion neurones. Br J Pharmacol. 1991; 102(1):272-6. PMC: 1917899. DOI: 10.1111/j.1476-5381.1991.tb12165.x. View

Bruss M, Barann M, Eucker T, Gothert M, Bonisch H . Modified 5-HT3A receptor function by co-expression of alternatively spliced human 5-HT3A receptor isoforms. Naunyn Schmiedebergs Arch Pharmacol. 2000; 362(4-5):392-401. DOI: 10.1007/s002100000342. View

Amano T, Richelson E, Nirenberg M . Neurotransmitter synthesis by neuroblastoma clones (neuroblast differentiation-cell culture-choline acetyltransferase-acetylcholinesterase-tyrosine hydroxylase-axons-dendrites). Proc Natl Acad Sci U S A. 1972; 69(1):258-63. PMC: 427587. DOI: 10.1073/pnas.69.1.258. View

Reith M . [14C]guanidinium ion influx into Na+ channel preparations from mouse cerebral cortex. Eur J Pharmacol. 1990; 188(1):33-41. DOI: 10.1016/0922-4106(90)90245-s. View

10.

Reiser G, Hamprecht B . Substance P and serotonin act synergistically to activate a cation permeability in a neuronal cell line. Brain Res. 1989; 479(1):40-8. DOI: 10.1016/0006-8993(89)91333-4. View

11.

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

12.

Derkach V, Surprenant A, North R . 5-HT3 receptors are membrane ion channels. Nature. 1989; 339(6227):706-9. DOI: 10.1038/339706a0. View

13.

Lovinger D, Zhou Q . Alcohols potentiate ion current mediated by recombinant 5-HT3RA receptors expressed in a mammalian cell line. Neuropharmacology. 1994; 33(12):1567-72. DOI: 10.1016/0028-3908(94)90131-7. View

14.

Barann M, Dilger J, Bonisch H, Gothert M, Dybek A, Urban B . Inhibition of 5-HT3 receptors by propofol: equilibrium and kinetic measurements. Neuropharmacology. 2000; 39(6):1064-74. DOI: 10.1016/s0028-3908(99)00205-1. View

15.

Hargreaves A, Lummis S, Taylor C . Ca2+ permeability of cloned and native 5-hydroxytryptamine type 3 receptors. Mol Pharmacol. 1994; 46(6):1120-8. View

16.

Kilpatrick G, Jones B, Tyers M . Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature. 1987; 330(6150):746-8. DOI: 10.1038/330746a0. View

17.

Aapro M . 5-HT3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis. Drugs. 1991; 42(4):551-68. DOI: 10.2165/00003495-199142040-00002. View

18.

Barann M, Molderings G, Bruss M, Bonisch H, Urban B, Gothert M . Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site. Br J Pharmacol. 2002; 137(5):589-96. PMC: 1573528. DOI: 10.1038/sj.bjp.0704829. View

19.

Jackson M, Yakel J . The 5-HT3 receptor channel. Annu Rev Physiol. 1995; 57:447-68. DOI: 10.1146/annurev.ph.57.030195.002311. View

20.

Kooyman A, Zwart R, Vijverberg H . Tetraethylammonium ions block 5-HT3 receptor-mediated ion current at the agonist recognition site and prevent desensitization in cultured mouse neuroblastoma cells. Eur J Pharmacol. 1993; 246(3):247-54. DOI: 10.1016/0922-4106(93)90038-b. View